ℹ️
🇬🇧
Search
Search for people relevant for "developer"
developer
Person
Class
Person
Publication
Programmes
Export current view
prof. MUDr. Pavel Klener Ph.D.
Academic staff at First Faculty of Medicine
112 publications
Publications
publication
Staging and Treatment Response Evaluation in Malignant Lymphomas - Czech Lymphoma Study Group Recommendations According to Criteria Revised in 2014 (Lugano Classification)
2016 |
First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
publication
Mantle cell lymphoma-variant Richter syndrome: Detailed molecular-cytogenetic and backtracking analysis reveals slow evolution of a pre-MCL clone in parallel with CLL over several years
2016 |
First Faculty of Medicine, Second Faculty of Medicine
publication
Significantly higher numbers of proB cells in healthy Caucasians compared to Asians: Is there association with incidence of CLL?
2016 |
First Faculty of Medicine
publication
Pevonedistat, a NEDD8-activating enzyme inhibitor, is active in mantle cell lymphoma and enhances rituximab activity in vivo
2016 |
First Faculty of Medicine
publication
Malignant Lymphomas - Past, Present and Future
2015 |
First Faculty of Medicine
publication
Mouse models of mantle cell lymphoma, complex changes in gene expression and phenotype of engrafted MCL cells: implications for preclinical research
2014 |
First Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Resistance to TRAIL in mantle cell lymphoma cells is associated with the decreased expression of purine metabolism enzymes
2013 |
First Faculty of Medicine
publication
The role of apoptosis in cancer development and treatment: focusing on the development and treatment of hematologic malignancies
2010 |
First Faculty of Medicine
publication
The cultivation of human multipotent mesenchymal stromal cells in clinical grade medium for bone tissue engineering
2009 |
First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
TRAIL-induced apoptosis of HL60 leukemia cells: two distinct phenotypes of acquired TRAIL resistance that are accompanied with resistance to TNF alpha but not to idarubicin and cytarabine
2009 |
First Faculty of Medicine
Load more publications (102)
Loading network view...